Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2008 1
2009 1
2012 1
2013 1
2014 1
2015 2
2016 1
2018 1
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Dermatological adverse events with taxane chemotherapy.
Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Sibaud V, et al. Among authors: deslandres m. Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833. Eur J Dermatol. 2016. PMID: 27550571 Free PMC article. Review.
Synchronous intrathyroid metastasis from undifferentiated endometrial sarcoma.
Simon C, Grunenwald S, Soule-Tholy M, Escourrou G, Vezzosi D, Deslandres M, Vidal F, Bennet A, Caron P. Simon C, et al. Among authors: deslandres m. Thyroid. 2013 Jul;23(7):902-3. doi: 10.1089/thy.2012.0594. Epub 2013 Jun 21. Thyroid. 2013. PMID: 23360518 No abstract available.
18F-FDG PET/CT Identifies Predictors of Survival in Patients with Locally Advanced Cervical Carcinoma and Paraaortic Lymph Node Involvement to Allow Intensification of Treatment.
Leray H, Gabiache E, Courbon F, Brenot-Rossi I, Colineaux H, Lepage B, Lambaudie E, Martinez A, Voglimacci M, Weyl A, Deslandres M, Ducassou A, Motton S, Vaysse C, Chantalat E. Leray H, et al. Among authors: deslandres m. J Nucl Med. 2020 Oct;61(10):1442-1447. doi: 10.2967/jnumed.119.238824. Epub 2020 Feb 7. J Nucl Med. 2020. PMID: 32034109 Free article.
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.
Betrian S, Angeles MA, Gil Moreno A, Cabarrou B, Deslandres M, Ferron G, Mery E, Floquet A, Guyon F, Pérez-Benavente A, Spagnolo E, Rychlik A, Gladieff L, Hernández Gutiérrez A, Martinez A. Betrian S, et al. Among authors: deslandres m. Int J Gynecol Cancer. 2022 Jul 20:ijgc-2021-003313. doi: 10.1136/ijgc-2021-003313. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35858711
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer.
Bennouna J, Deslandres M, Senellart H, de Labareyre C, Ruiz-Soto R, Wixon C, Botbyl J, Suttle AB, Delord JP. Bennouna J, et al. Among authors: deslandres m. Invest New Drugs. 2015 Feb;33(1):138-47. doi: 10.1007/s10637-014-0142-1. Epub 2014 Sep 24. Invest New Drugs. 2015. PMID: 25248752 Clinical Trial.
11 results